XML 71 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
Collaboration, License, and Other Agreements - Teva Narrative (Details) - USD ($)
$ in Millions
12 Months Ended 72 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2016
Dec. 31, 2021
Disaggregation of Revenue [Line Items]          
Revenues $ 16,071.7 $ 8,497.1 $ 6,557.6    
Teva          
Disaggregation of Revenue [Line Items]          
Up-front payment received       $ 250.0  
Revenues         $ 120.0
Aggregate future development milestone payments the Company is eligible to receive 340.0        
Collaborative arrangement, additional eligible aggregate payments 1,890.0        
Remaining performance obligation $ 87.4       $ 87.4
Teva | Other operating income          
Disaggregation of Revenue [Line Items]          
Cumulative catch-up adjustment to revenue, modification of contract   $ (25.6)